Home » Newsletters » BioWorld Science

BioWorld Science

July 25, 2006

View Archived Issues

Intranasal insulin demonstrates therapeutic benefits in AD

Facial rejuvenation product ICX-RHY completes phase I

Novartis steps up activities for flu cell culture vaccines

UMMS signs license and research agreements with CytoDyn for flu vaccines

German approval for new phosphate binding agent OsvaRen

Orphan drug designations for YSPSL in U.S. and Europe

Wyeth and ArQule present new gamma secretase inhibitors with Notch-sparing selectivity

Ovation launches NeoProfen for premature infants with patent ductus arteriosus

Nanobodies targeting amyloid-beta peptide

Studies detail metabolic effects, efficacy of aripiprazole in schizophrenia

Japanese researchers present novel Abeta aggregation inhibitor

Pfizer begins Exubera introduction with education and training program

aP2 implicated in allergic airway inflammation: possible link between metabolic and immune disorders

Ostarine phase II proof-of-concept study completes enrollment

Aridol filed for approval in Switzerland

Phase III begins for Actos + TAK-536 combination product

Novel BiTE molecule presented

Lilly and Alcon sign marketing collaboration for Arxxant

NDA submission for SPD-465 for ADHD

Foamix's betamethasone foam shows efficacy and good usability in psoriasis

New compounds for respiratory disorders reported in recent patent literature

Patents claim agents with potential for treatment of inflammatory disorders

Radiotherapy using a peptidic vector shows promise in malignant glioma treatment

Sanvar filed for esophageal variceal bleeding in France

In vitro and in vivo pharmacology of novel GluK5 receptor antagonist

Opana and Opana ER now available

Elaprase approved for Hunter's syndrome

New approvable letter for Thelin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...